r.chukwu
TL2 Moderator · Ibadan
Contributes reviews on supplier material. Based in Ibadan.
Joined 26 September 2025 · last posted 6d · groups: newcomer-guides
101 posts, newest first. Showing up to 150.
-
Journal club: LEADER as the historical anchor Replied, post #108 · Evidence › Journal club · 22 Jul 2026 · 21 likes I read post #106 twice before replying, because I had assumed the opposite. Session format: read the paper before posting. The discussion is much better when everyone…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #100 · Analytics › Home & field testing · 19 Jul 2026 · 3 likes post #99 answers the question as asked. The question underneath it is different. Sample handling matters: if a sample is contaminated or degraded before testing, the…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #35 · Practice › Interactions · 17 Jul 2026 · 1 like This follows post #32 rather than contradicting it. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #57 · Clinical › Bloodwork · 16 Jul 2026 · 2 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Common supplements people ask about, assessed one at a time Replied, post #47 · Practice › Interactions · 14 Jul 2026 · 0 likes I read post #45 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Asking a follow-up: new topic or new reply? Replied, post #49 · Start Here › How to Ask · 12 Jul 2026 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #25 · Clinical › Comorbidities · 11 Jul 2026 · 3 likes post #24 answers the question as asked. The question underneath it is different. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not…
-
Micro-titration: a disputed topic, argued properly Replied, post #102 · Practice › Dosing & titration · 9 Jul 2026 · 25 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
How shortages have affected compounding permissions Replied, post #22 · Access › Shortages · 8 Jul 2026 · 1 like post #21 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #26 · Compounds › Retatrutide · 7 Jul 2026 · 14 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Follow-up: UK access routes, dated and sourced Replied, post #9 · marked as the solution · Regional › UK & Ireland · 4 Jul 2026 · 7 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
Revisiting: The best-written scientific paper you have read Replied, post #63 · Lounge › Off topic · 1 Jul 2026 · 1 like Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Journal club: what we got wrong in an earlier session Replied, post #42 · Evidence › Journal club · 30 Jun 2026 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #47 · Clinical › Comorbidities · 28 Jun 2026 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #59 · Analytics › Home & field testing · 27 Jun 2026 · 4 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #47 · Analytics › HPLC & UHPLC · 22 Jun 2026 · 8 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Revisiting: Body image changing more slowly than the body Replied, post #7 · Wellbeing › Mental health · 18 Jun 2026 · 1 like Picking up post #4: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…
-
Racemisation and why it is invisible to a mass measurement Replied, post #100 · Analytics › Impurities & related substances · 14 Jun 2026 · 10 likes This follows post #97 rather than contradicting it. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #10 · Clinical › Bloodwork · 12 Jun 2026 · 0 likes Worth separating two things that post #6 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #11 · Start Here › Welcome · 7 Jun 2026 · 25 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #10 · Analytics › HPLC & UHPLC · 6 Jun 2026 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Why this subcategory is stricter about sourcing than most Replied, post #38 · Compounds › Secretagogues & GH axis · 3 Jun 2026 · 5 likes post #37 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #72 · Practice › Storage & stability · 2 Jun 2026 · 13 likes I read post #70 twice before replying, because I had assumed the opposite. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those…
-
Citation sweep results: how many references did not say what was claimed Replied, post #102 · Meta › Wiki maintenance · 26 May 2026 · 1 like This follows post #99 rather than contradicting it. Outdated external links: if a maintained page links to external sources and those links are broken or pages have…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #15 · Start Here › Welcome · 19 May 2026 · 24 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #17 · Compounds › Oral incretins · 15 May 2026 · 0 likes Worth separating two things that post #13 runs together. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #45 · Practice › Reconstitution · 14 May 2026 · 0 likes I read post #43 twice before replying, because I had assumed the opposite. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort…
-
Does a peptide degrade silently, with no visual change? Replied, post #14 · Practice › Storage & stability · 22 Apr 2026 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #41 · Sourcing › Logistics · 13 Apr 2026 · 7 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Follow-up: Search filters: what is missing Replied, post #70 · Meta › Site feedback · 6 Apr 2026 · 0 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
Choosing which test to pay for, given a fixed budget Replied, post #53 · Sourcing › Independent verification · 4 Apr 2026 · 8 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Grapefruit: why this class is not the class that cares Replied, post #65 · Practice › Interactions · 21 Mar 2026 · 8 likes On post #61 — agreed on the reasoning, with one qualification. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class…
-
Search filters: what is missing Replied, post #36 · Meta › Site feedback · 15 Mar 2026 · 7 likes Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider.
-
Revisiting: Maintainer handover: how it works Replied, post #37 · Meta › Wiki maintenance · 7 Mar 2026 · 2 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict.
-
Forced degradation studies: designing one that is informative Replied, post #14 · Analytics › Method validation · 3 Mar 2026 · 3 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #35 · Research Methods › N-of-1 designs · 23 Feb 2026 · 29 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Moderation log format change Replied, post #29 · Meta › Announcements · 15 Feb 2026 · 27 likes This follows post #26 rather than contradicting it. When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #23 · Outcomes › Body composition · 5 Feb 2026 · 0 likes Picking up post #20: that is the part I would want checked first. DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #52 · Documentation › Wiki requests · 24 Jan 2026 · 2 likes On post #48 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #28 · Data & Tools › Calculators · 22 Jan 2026 · 20 likes Coming back to post #26, because the follow-up matters more than the original answer. The calculators maintained on this site are open-source and verifiable. They are…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #92 · Compounds › Semaglutide · 13 Jan 2026 · 11 likes Coming back to post #90, because the follow-up matters more than the original answer. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent…
-
Reading an interaction checker output critically Replied, post #89 · Practice › Interactions · 11 Jan 2026 · 2 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
A partial dose because the pen emptied mid-injection Replied, post #102 · Practice › Administration · 10 Jan 2026 · 22 likes Worth separating two things that post #98 runs together. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away,…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #28 · Practice › Interactions · 4 Jan 2026 · 0 likes I read post #26 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
When to stop reading forums, including this one Replied, post #69 · Wellbeing › Mental health · 31 Dec 2025 · 0 likes On post #65 — agreed on the reasoning, with one qualification. Social and relationship impacts: weight change affects how others perceive and interact with a person.…
-
Tracking a preprint to publication: a worked example Replied, post #139 · Evidence › Preprints · 14 Dec 2025 · 18 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Prescription requirements and telehealth models Replied, post #62 · Sourcing › Regulatory · 12 Dec 2025 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Amylin receptor signalling and satiety — what changed since Replied, post #3 · Pharmacology › Receptor biology · 9 Dec 2025 · 2 likes post #2 answers the question as asked. The question underneath it is different. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress…
-
Publication bias detection and its low power — does this still hold? Started this topic · Evidence › Meta-analyses · 28 Nov 2025 · 10 likes The question in the title: Publication bias detection and its low power — does this still hold? I will give what I have already checked below so nobody repeats it. I…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #64 · Compounds › Oral incretins · 21 Nov 2025 · 7 likes post #63 is right about the mechanism and I think understates the practical bit. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #72 · Analytics › COA interpretation · 17 Nov 2025 · 31 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #118 · Practice › Storage & stability · 3 Nov 2025 · 21 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #3 · Practice › Side effects · 12 Oct 2025 · 9 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 5 likes Worth separating two things that post #3 runs together. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose…
-
The headache that turns out to be dehydration Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 29 Sep 2025 · 0 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #126 · Evidence › Study critique · 16 Sep 2025 · 32 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #75 · Devices › Cold chain · 11 Sep 2025 · 0 likes Picking up post #72: that is the part I would want checked first. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light…
-
Guidelines revision: what changed and why — one year on Replied, post #14 · Meta › Announcements · 8 Sep 2025 · 5 likes Picking up post #11: that is the part I would want checked first. Staff-only posts: some announcements are visible only to staff (concerning internal operations).…
-
Documentation that appears only after payment Replied, post #19 · Sourcing › Red flags · 6 Sep 2025 · 4 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #55 · Practice › Dosing & titration · 5 Sep 2025 · 27 likes On post #51 — agreed on the reasoning, with one qualification. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #26 · Compounds › Tirzepatide · 28 Aug 2025 · 29 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #83 · Evidence › Journal club · 21 Aug 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Asking about a compound your prescriber has not heard of Replied, post #131 · Clinical › Prescriber conversations · 19 Aug 2025 · 22 likes On post #127 — agreed on the reasoning, with one qualification. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours…
-
Hypertension improvement and when medication needs revisiting Replied, post #7 · Clinical › Comorbidities · 13 Aug 2025 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Interactions between comorbidities: diabetes and kidney disease together change the…
-
Are there stupid questions here? A staff answer, at length Replied, post #32 · Start Here › Welcome · 2 Aug 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
How to research a compound with no human data without deceiving yourself Replied, post #38 · Compounds › Other compounds · 1 Aug 2025 · 1 like When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
A preprint whose numbers changed substantially at publication Replied, post #5 · Evidence › Preprints · 29 Jul 2025 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Journal club: STEP 8 and the fairness of the comparator dose Replied, post #3 · Evidence › Journal club · 23 Jul 2025 · 17 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #81 · Compounds › Semaglutide · 22 Jul 2025 · 0 likes I read post #79 twice before replying, because I had assumed the opposite. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #15 · Compounds › Secretagogues & GH axis · 21 Jul 2025 · 17 likes Worth separating two things that post #11 runs together. Development history is more informative than speculation: ipamorelin was investigated clinically for…
-
Why the timeline is on the right and not the left Replied, post #42 · Meta › Site feedback · 17 Jul 2025 · 7 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #51 · Sourcing › Regulatory · 15 Jul 2025 · 20 likes On post #47 — agreed on the reasoning, with one qualification. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is…
-
Ipamorelin selectivity claims and where they came from Replied, post #56 · Compounds › Secretagogues & GH axis · 12 Jul 2025 · 28 likes Coming back to post #54, because the follow-up matters more than the original answer. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone…
-
Consistent declarations and why they matter more than clever ones — a second dataset Replied, post #3 · marked as the solution · Sourcing › Logistics · 12 Jul 2025 · 31 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Interpreting a composition change that is within the error bars Replied, post #11 · Outcomes › Body composition · 3 Jul 2025 · 18 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why plausible mechanism is not evidence of effect Replied, post #18 · Compounds › Repair & healing peptides · 28 Jun 2025 · 26 likes This follows post #15 rather than contradicting it. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are…
-
Half-life, steady state, and accumulation worked through Replied, post #82 · Pharmacology › Pharmacokinetics · 8 Jun 2025 · 31 likes This follows post #79 rather than contradicting it. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed…
-
Half-life, steady state, and accumulation worked through Replied, post #61 · Pharmacology › Pharmacokinetics · 3 Jun 2025 · 4 likes On post #57 — agreed on the reasoning, with one qualification. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance…
-
A well-designed study with a badly written abstract Replied, post #82 · Evidence › Study critique · 14 May 2025 · 10 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #11 · Compounds › Repair & healing peptides · 10 May 2025 · 3 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
A supplier that answers analytical questions with restated claims Replied, post #57 · Sourcing › Red flags · 14 Apr 2025 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Validating a method you did not develop — does this still hold? Replied, post #63 · Analytics › Method validation · 2 Mar 2025 · 31 likes Coming back to post #61, because the follow-up matters more than the original answer. Transfer between laboratories: a method can be transferred from one lab to…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #14 · Compounds › Semaglutide · 17 Feb 2025 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Protein density versus volume when you cannot eat much Replied, post #6 · Nutrition & Training › Protein & intake · 22 Jan 2025 · 13 likes I read post #4 twice before replying, because I had assumed the opposite. Timing of protein: spreading protein intake across the day, with some at each meal, is more…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #58 · Sourcing › Regulatory · 6 Jan 2025 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #123 · Compounds › Oral incretins · 28 Dec 2024 · 1 like The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
A promotion I argued against, and why I lost Replied, post #30 · Documentation › Doc review · 15 Dec 2024 · 4 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
What changed in 2026, by region Replied, post #8 · marked as the solution · Access › International · 4 Dec 2024 · 20 likes Coming back to post #6, because the follow-up matters more than the original answer. Customs and import outcomes: different routes have different seizure rates. Some…
-
[2026 update] New subcategory: rationale and scope Replied, post #33 · Meta › Announcements · 30 Nov 2024 · 5 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #29 · Nutrition & Training › Protein & intake · 30 Nov 2024 · 1 like post #28 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Why "any advice?" is the least effective ending for a post Replied, post #82 · Start Here › How to Ask · 28 Nov 2024 · 28 likes post #81 answers the question as asked. The question underneath it is different. Lab result questions: state the result, the reference interval, and what else is on the…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #51 · Clinical › Prescriber conversations · 11 Nov 2024 · 32 likes I read post #49 twice before replying, because I had assumed the opposite. Questions about dose: asking "how will we determine whether this dose is working for me" gets…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #25 · Practice › Interactions · 10 Nov 2024 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #59 · Devices › Syringes & needles · 2 Nov 2024 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #95 · Analytics › COA interpretation · 25 Oct 2024 · 26 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #56 · Analytics › Method validation · 21 Oct 2024 · 12 likes On post #52 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #6 · Compounds › Oral incretins · 18 Oct 2024 · 3 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #64 · Clinical › Bloodwork · 28 Sep 2024 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #41 · Compounds › Retatrutide · 16 Sep 2024 · 10 likes post #40 answers the question as asked. The question underneath it is different. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
Blind submission and why it changes minds Replied, post #57 · Sourcing › Independent verification · 9 Sep 2024 · 4 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
How to ask for a dose change without antagonising anyone Replied, post #11 · Clinical › Prescriber conversations · 3 Aug 2024 · 0 likes This follows post #8 rather than contradicting it. Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any…